Table of Contents

company-logo

Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1/2 clinical trial, as well as used to engage the Fc gamma receptor, or Fc?R to activate dendritic cells and macrophages and to promote antibody-dependent cellular cytotoxicity, or ADCC activity. Iteos Therapeutics, Inc. was founded in 2011 and is headquartered in Watertown, Massachusetts.

iTeos Therapeutics Dividend Announcement

• iTeos Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on iTeos Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

iTeos Therapeutics Dividend History

iTeos Therapeutics Dividend Yield

iTeos Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing iTeos Therapeutics stock? Use our calculator to estimate your expected dividend yield:

iTeos Therapeutics Financial Ratios

P/E ratio-3.00
PEG ratio-0.03
P/B ratio0.58
ROE-20.11%
Payout ratio0.00%
Current ratio14.80
Quick ratio14.80
Cash Ratio3.36

iTeos Therapeutics Dividend FAQ

Does iTeos Therapeutics stock pay dividends?
iTeos Therapeutics does not currently pay dividends to its shareholders.
Has iTeos Therapeutics ever paid a dividend?
No, iTeos Therapeutics has no a history of paying dividends to its shareholders. iTeos Therapeutics is not known for its dividend payments.
Why doesn't iTeos Therapeutics pay dividends?
There are several potential reasons why iTeos Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will iTeos Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While iTeos Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is iTeos Therapeutics a dividend aristocrat?
iTeos Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is iTeos Therapeutics a dividend king?
iTeos Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is iTeos Therapeutics a dividend stock?
No, iTeos Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy iTeos Therapeutics stocks?
To buy iTeos Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy iTeos Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.